mind cure

Psychedelic Business Spotlight – February 18

February 18, 2022June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to MAPS; Cathie Wood eyes more psychedelic stocks.

Psychedelic Business Spotlight: October 29

October 29, 2021June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: MindMed’s MDMA research pipeline to treat Autism Spectrum Disorder; Cybin EMBARKs; Awakn and MindCure partner to heal alcoholism.

Psychedelic Business Spotlight: October 1, 2021

October 1, 2021June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: more evidence supporting ketamine for depression; a new use for MDMA; Lobe Sciences makes a leap in treating PTSD; Delix raises big bucks; and BetterLife Pharma patents solution for cluster headaches.

Mind Cure Health Targeting Hypoactive Sexual Desire Disorder with MDMA

September 27, 2021June 2, 2024 Business, Learn

“Women’s desire issues have not been adequately addressed to date, and we believe this treatment incorporating MDMA and psychotherapy has real promise,” says CEO Kelsey Ramsden

Psychedelic Business Spotlight: July 30, 2021

July 30, 2021June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: More psychedelic-assisted therapy clinics, recruitment begins in early DMT trial, and Filament gets more Health Canada love.

Psychedelic Business Spotlight: July 16, 2021

July 16, 2021June 2, 2024 Business, Learn, Stock Reports

This week in psychedelic business news: A generous donation to advance MDMA research, psilocybin for end-of-life anxiety, and provisional patents filed for synthesizing ibogaine.

End of content